resveratrol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on diastolic blood pressure (office/clinic)
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull result“Data analyzed using the multivariate ANOVA model revealed that resveratrol’s effects on systolic and diastolic blood pressure were not statistically significant compared with placebo (Table 3).”
Quoted verbatim from Preliminary, randomized, double-blinded, placebo-controlled cross-over study with resveratrol in hypertensive patients.. - Study
- crossover
- Participants
- 16
- Duration
- 4 weeks
- Dose
- 500 mg twice daily, oral
- Population
- pre-hypertensive and stage-1 hypertensive adults aged 20-60 years, Iran; primary outcome; 2 x 2 crossover, 16 completers analysed
Preliminary, randomized, double-blinded, placebo-controlled cross-over study with resveratrol in hypertensive patients.2025PMID:40854984Permalink
Keep reading
- Everything the graph holds on resveratrol
- Every compound studied against Diastolic blood pressure (office/clinic)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M0XYT27ERXX1PF14P49SRT7W